Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
where do u see it ? source?
great NEWS here. RM is on the way still. NO FAKER
$GASE looks like the Curadox Biopharma merger is very much real! Per CEO, Sean Martin, applied for OTCIQ access 6 weeks ago. Audits on the acquisition almost done! Hit .39 first time around before fake Twitter! Should be current b4 deadline. @Suits_n_stocks @thommic @KickoStocks pic.twitter.com/hkfYQdjhP1
— JA (@BinDaddys) August 20, 2021
BRTX at that moment is a real disaster. Good bye then
ME TOO ! 2 Dollars plus
DAMNS n u OWN 75 Millies? DAMN u will get filty rich dude
GREAT NEWS HERE
---
Oncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharmaceuticals, Inc.Press Release | 08/19/2021
SAN FRANCISCO, CA / ACCESSWIRE / August 19, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) With much anticipation, Oncology Pharma, Inc. has finalized a Co-Development Agreement with NanoSmart Pharmaceuticals, Inc. Oncology Pharma will pursue the early feasibility and nonclinical development of a dactinomycin nanoemulsion drug product intended for the treatment of pediatric cancer.
Oncology Pharma is pleased to be moving forward with the development of its first product based upon licensed technology in Oncology Pharma's growing portfolio of licensed intellectual property. Oncology Pharma's agreement with NanoSmart Pharmaceuticals will allow for continued development of a proprietary lead-candidate formulation leading to the submission of an Investigational New Drug application to the US FDA. This phase of cancer drug development is intended to also support potential applications in veterinary oncology.
Oncology Pharma is excited to be combining efforts with NanoSmart Pharmaceuticals to pursue research and develop of improved treatments for pediatric cancers.
ABOUT ONCOLOGY PHARMA, INC.
ONCOLOGY PHARMA, INC. (OTCPK: ONPH) (the 'Company') is currently engaging in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
ABOUT NANOSMART PHARMACEUTICALS, INC.
NanoSmart® Pharmaceuticals is a privately-held California corporation that is developing nanoparticle drug delivery platforms, including utilization of anti-nuclear antibody (ANA) to target existing drug therapies to areas of necrosis present in virtually all solid cancer tumors.
FORWARD LOOKING STATEMENTS
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include risks related to licensing arrangements and joint ventures, including the need to negotiate the definitive agreements for the relationships; possible failure to realize anticipated benefits of business relationships, and costs of providing funding to these business relationships. Other risks and uncertainties relating to the Company include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners and with any strategic or joint venture partners; the impact of competition; the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; management of growth; and, other risks and uncertainties. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position.
CONTACTS:
For additional Information, please contact the Oncology Pharma at:
One Sansome Street, Suite 3500
San Francisco, CA 94104
Phone: 415-869-1038
Fax: 415-946-8801
website: www.oncology-pharma.com
email: info@oncology-pharma.com
SOURCE: Oncology Pharma Inc.
i thinke the same as you !
me holding also some nice shares-. not selling until 50 CENTS . never ever.
WEAK HANDS OUT! PAPER HANDS OUT !: STRONH HANDS BACK IN ! NOW BOOOMMMMMMMMM
UPPPPP - GO ICOA AAAAA
GREAT START IN THAT DAY ... 1 CENT comings for ICOARs
$ICOA . watch these huge tweets by famous influencers
$ICOA - HIGH OF THA YEAR ! as is predicted for today. Big lift off coming. same pattern as $MJWL - did pic.twitter.com/EyP4cpYiPF
— Dr. W.-Chun Chenn (@WenChunChenn) August 17, 2021
i guess man you are right!
SO SO GREAT ! BIG SPIKE COMING all go in $ICOA
the big guy, called it. he has the best alerts on twitter
$ICOA - HUGE LIFT OFF ! FILLINGS COMING SOON. THEN BOOOMMMM -> CURRENT PINK- same Cheif officer like in $MJWL ( that ran to 26 CENTS - **OMG *** ) pic.twitter.com/cBugtABTLY
— Dr. W.-Chun Chenn (@WenChunChenn) August 16, 2021
ICOA HUGE MOVE COMING ! Big influencers are in on TWITTER
Watch $ICOA .... WHO ALERTED it back in low prices? Dr. CHENN ! himself. -> better go in ! HUGE RM coming like $MJWL . SAME CONULTNAT THERE . Mrs. KIM
— Dr. W.-Chun Chenn (@WenChunChenn) August 16, 2021
real NO SELLINg here. Holding ALL here. ! imagine Q DROP and RM by LAZAR then KABOOM !
no... no noooo... this is bullshit here / HOLD ON to your GASE-shares
THE MERGER WILL COME THROUGH YES ! NO SELLING DUDES !
DREAM BIG BOYS AND GIRLS: THIS magic can happen.
3 to 5 Dollars man !
SO GREAT ! here . Buyout and target price is between
1 to 5 Dollar s!
SO FASTEN your seat belt boys + girls !
Do not lie here Around ! stupid BS talk . Go away here you full - IDIOT !
IF BUYOUT ! like KITE PHRMA - 100 x UPLIFT from here ! 12 Billions !
Makes 3 DOLLARS ! i go confirm with that!
i am very serious dude
yes dude . ofcourse it is
great great UPLIFT , like yesterday, some levels all of a sudden higher here with $RGBP
GOLDEN TIMES AHEAD ! - we are golden golden golden " when fillings hit like at $MJWL ------ GO $ICOA
yYES dude ... the NEXT MJWL type of Move. fasten your SEAT BELT gboys and girls !
WE call it FRONTLOADING ! u get MUCH SHARES " at a low level area . Better than chasing that RM STock later. Why NOT ?
EPIC RUN with $ICOA STARTNG ! i called it weeks ago ! better BE ALL IN GUYSSSSS
THIS IS JUST THE WONDERFUL BEGINNING HeRE !
great man thats a lot .> GOOD LUCK us both !
GOOD PRICE ! hope u bought 100 milions of shares
active
they are not revoked dude.
everybody knows what happened with $MJWL
JUST THE BEGINNING SAME PATTERN !
M E GUESS it is the BEGINNING of tha $MJWL LIKE RUN !
DOLLAR BABY IN DA MAKING ! gooo $RGBP
DOLLAR LAND coming - INBOUND
yes we go to 0.05 Dollars
BLUU - 0.25 DOLLARS nice PT - in my opinion
HUGE investor-influencers are in this play ---- Dr. Chen
$GASE . all my followers wake up. you know my best picks. here i found a top quality pick for extraordinary GAINS
— Dr. W.-Chun Chenn (@WenChunChenn) July 29, 2021
GASE~~.0.1127~~Will be $10.00!+++ PPS soon,READ IS HUGEEEEEEEEEEEE 🚀🚀💵💵💵
Quote:
merger with a company within a market valued at 38 billion dollars a year https://t.co/AZ7voWNRYZ